Abstract
The recent report from the American Academy of Pediatrics on the prevention of iron deficiency and iron deficiency anemia recommended increased iron intake for breast fed infants beginning at 4 months of age. This recommendation has not been without controversy. This paper will review the reasoning behind these new recommendations and include a physiologic review of iron metabolism as well as its physiologic importance including its role in neurodevelopment. It will review the diagnosis of both iron deficiency and iron deficiency anemia and how to prevent them in the breastfed infant. This includes introducing medicinal iron at 4 months of age and introducing foods that are rich in heme iron (red meat) when complementary feedings are introduced.
Keywords: Infants, breastfeeding, iron deficiency, iron deficiency anemia, neuroedevelopment
Current Pediatric Reviews
Title:The Iron Requirement of Breastfeeding Infants
Volume: 8 Issue: 4
Author(s): Frank R. Greer
Affiliation:
Keywords: Infants, breastfeeding, iron deficiency, iron deficiency anemia, neuroedevelopment
Abstract: The recent report from the American Academy of Pediatrics on the prevention of iron deficiency and iron deficiency anemia recommended increased iron intake for breast fed infants beginning at 4 months of age. This recommendation has not been without controversy. This paper will review the reasoning behind these new recommendations and include a physiologic review of iron metabolism as well as its physiologic importance including its role in neurodevelopment. It will review the diagnosis of both iron deficiency and iron deficiency anemia and how to prevent them in the breastfed infant. This includes introducing medicinal iron at 4 months of age and introducing foods that are rich in heme iron (red meat) when complementary feedings are introduced.
Export Options
About this article
Cite this article as:
R. Greer Frank, The Iron Requirement of Breastfeeding Infants, Current Pediatric Reviews 2012; 8 (4) . https://dx.doi.org/10.2174/157339612803307741
DOI https://dx.doi.org/10.2174/157339612803307741 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Small Molecule Inhibitors of Multidrug Resistance Gene (MDR1) Expression: Preclinical Evaluation and Mechanisms of Action
Current Cancer Drug Targets Circumventing Immune Tolerance Through Epigenetic Modification
Current Pharmaceutical Design Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53<sup>wildtype</sup> JVM-2 But Not Towards p53<sup>mutated</sup> BJAB Leukemic Cells
Current Medicinal Chemistry Role of Genetic and Epigenetic Factors in Oral Squamous Cell Carcinoma - A Structured Review
Recent Patents on Biomarkers Sjogrens Syndrome and Lymphoma Development
Current Immunology Reviews (Discontinued) Polo-Like Kinases Inhibitors
Current Medicinal Chemistry Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Current Genomics Phenotypic Alteration of Bone Marrow HSC and Microenvironmental Association in Experimentally Induced Leukemia
Current Stem Cell Research & Therapy Gene Therapeutic Approaches for Immune Modulation in AIDS
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry From Conformation to Interaction: Techniques to Explore the Hsp70/ Hsp90 Network
Current Protein & Peptide Science Chronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover
Current Drug Metabolism Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia
Reviews on Recent Clinical Trials Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer
Current Topics in Medicinal Chemistry Thalidomide–A Notorious Sedative to a Wonder Anticancer Drug
Current Medicinal Chemistry Role of Nutrients and Phyto-compounds in the Modulation of Antimicrobial Resistance
Current Drug Metabolism Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays
Anti-Cancer Agents in Medicinal Chemistry Pyrimidine-fused Dinitrogenous Penta-heterocycles as a Privileged Scaffold for Anti-Cancer Drug Discovery
Current Topics in Medicinal Chemistry Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs
Current Medicinal Chemistry DNA Methylation as a Target of Epigenetic Therapeutics in Cancer
Anti-Cancer Agents in Medicinal Chemistry Targeted Strategies in the Treatment of Primary Gastric Lymphomas: From Rituximab to Recent Insights into Potential New Drugs
Current Medicinal Chemistry